中文 | English
Return
Total: 334 , 1/34
Show Home Prev Next End page: GO
Author:(Jun-xing DONG)

1.Pharmacoeconomic Evaluation of Manicol vs. Glycerol Fructose for Brain Edema after Cerebral Infarction

Jun XING ; Jing CHENG ; Chuanhai DONG

China Pharmacy 2001;0(08):-

2.Tanreqing Injection Versus Cibavirin for Children's Viral Pneumonia:Cost-Effectiveness Analysis

Pengfei XU ; Guangchen WEI ; Minyi SI ; Jun XING ; Chuanhai DONG

China Pharmacy 2005;0(23):-

3.Quality Standard Improvement for Qingyuantiaozhi Capsules

Limei ZHANG ; Jun LI ; Yang CHU ; Dong WANG ; Cheng PENG ; Rong GUO ; Jianhua XING ; Jun WU

China Pharmacist 2016;19(10):1972-1974,1975

5.Carriage rates of class 1, class 2 integrons as well as ISCR1 in Shigella isolates and their relationship with drug resistance

Lijuan DONG ; Xian YANG ; Jun WANG ; Wei QI ; Xing LYU ; Fan LIANG

Tianjin Medical Journal 2015;(4):400-403

6.Chemical constituents of Rannunculus chinensis Bunge.

Qing-sheng, LI ; Jian, LI ; Hai-long, YIN ; Jun-xing, DONG

Bulletin of The Academy of Military Medical Sciences 2010;34(1):68-70

7.Chemical constituents from Solanum lyratum Thunb.

Hai-long, YIN ; Jian, LI ; Qing-sheng, LI ; Jun-xing, DONG

Bulletin of The Academy of Military Medical Sciences 2010;34(1):65-67

8.A Modified Method for Isolating DNA from Fungus

Ying-Hui ZHANG ; Dong-Sheng WEI ; Lai-Jun XING ; Ming-Chun LI ;

Microbiology 1992;0(03):-

9.On expression of VEGF-C and its receptor in breast carcinoma tissue and in peritumoral tissue and their clinic significance

Xiao-Jun MA ; Yong-Dong PU ; Jian-Miao HE ; Liang-Hong NI ; Hong-Xing JIA ;

Cancer Research and Clinic 1997;0(03):-

10.Identification of a mutation in the arginine vasopressin receptor 2 gene in a Chinese pedigree with congenital nephrogenic diabetes insipidus

Xue-Ru CHEN ; Yan DONG ; Jun YIN ; Hui-Li XING ; Qing SU ;

Chinese Journal of Endocrinology and Metabolism 1985;0(02):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 334 , 1/34 Show Home Prev Next End page: GO